PHIBRO ANIMAL HEALTH CORP - Class A Common Stock, par value $0.0001 per share (PAHC)

Historical Holders from Q2 2014 to Q4 2025

Symbol
PAHC on Nasdaq
Type / Class
Equity / Class A Common Stock, par value $0.0001 per share
Shares outstanding
40,568,426
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
19,599,540
Holdings value
$792,990,412
% of all portfolios
0%
Number of holders
215
Number of buys
116
Number of sells
102
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of PHIBRO ANIMAL HEALTH CORP - Class A Common Stock, par value $0.0001 per share (PAHC) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BFI Co., LLC 49% -1.2% $832,609,741 -$9,378,406 20,000,234 -1.1% BFI Co., LLC 11 Dec 2025
BlackRock, Inc. 16% $68,247,849 3,195,124 BlackRock, Inc. 31 Mar 2025
PZENA INVESTMENT MANAGEMENT LLC 3.6% -51% $15,461,009 -$15,741,679 723,830 -50% PZENA INVESTMENT MANAGEMENT LLC 31 Mar 2025
BRANDES INVESTMENT PARTNERS, LP 3.3% $14,156,297 662,748 Brandes Investment Partners, L.P. 31 Dec 2024
As of 30 Sep 2025 PHIBRO ANIMAL HEALTH CORP - Class A Common Stock, par value $0.0001 per share (PAHC) has 215 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 19,599,540 shares of 40,568,426 outstanding shares and own 48% of the company stock as of 30 Sep 2025.

Top 25 institutional shareholders of PHIBRO ANIMAL HEALTH CORP - Class A Common Stock, par value $0.0001 per share (PAHC) own 34% of the company based on 13F filings as of 30 Sep 2025

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
BlackRock, Inc. 8.4% 3,426,171 -1.9% 0% $138,622,879
VANGUARD GROUP INC 3.8% 1,525,709 -1.5% 0% $61,730,187
STATE STREET CORP 2.2% 894,036 -1.7% 0% $36,172,697
ACADIAN ASSET MANAGEMENT LLC 1.9% 785,820 +8.5% 0.06% $31,780,000
FMR LLC 1.5% 597,555 +903% 0% $24,177,071
RENAISSANCE TECHNOLOGIES LLC 1.4% 555,200 -9.1% 0.03% $22,463,392
GEODE CAPITAL MANAGEMENT, LLC 1.3% 547,160 -1.4% 0% $22,141,619
DIMENSIONAL FUND ADVISORS LP 1.2% 485,509 -13% 0% $19,641,321
Nuveen, LLC 1.2% 479,218 +4.2% 0.01% $19,389,160
MORGAN STANLEY 1.1% 436,042 -11% 0% $17,642,318
CastleKnight Management LP 0.99% 399,783 -25% 0.87% $16,175,220
Dana Investment Advisors, Inc. 0.88% 355,085 -9.6% 0.42% $14,366,739
Invesco Ltd. 0.79% 322,299 +23% 0% $13,040,217
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 0.74% 301,605 +9.6% 0.01% $12,202,938
Ranger Investment Management, L.P. 0.74% 299,910 -16% 0.85% $12,134,359
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.67% 271,163 +4.3% 0% $10,971,255
BARCLAYS PLC 0.66% 269,568 +47% 0% $10,906,721
Bank of New York Mellon Corp 0.66% 267,103 -0.66% 0% $10,806,984
Qube Research & Technologies Ltd 0.63% 255,353 +40% 0.01% $10,331,582
Capricorn Fund Managers Ltd 0.62% 252,928 3.4% $10,233,467
JPMORGAN CHASE & CO 0.59% 238,115 +1731% 0% $9,634,134
GLOBEFLEX CAPITAL L P 0.57% 231,499 +1.8% 1.4% $9,366,450
NORTHERN TRUST CORP 0.55% 221,861 -1.2% 0% $8,976,497
Allspring Global Investments Holdings, LLC 0.54% 218,894 0.01% $8,930,876
CRAWFORD INVESTMENT COUNSEL INC 0.54% 217,636 -7.8% 0.15% $8,805,556

Institutional Holders of PHIBRO ANIMAL HEALTH CORP - Class A Common Stock, par value $0.0001 per share (PAHC) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 1,639 $61,233 -$8,331 $37.36 2
2025 Q3 19,599,540 $792,990,412 -$21,506,319 $40.46 215
2025 Q2 20,349,724 $519,721,694 +$4,932,335 $25.54 192
2025 Q1 20,230,331 $431,882,609 -$6,976,168 $21.36 181
2024 Q4 20,760,076 $435,957,758 +$5,855,071 $21.00 171
2024 Q3 20,262,212 $456,562,588 +$4,957,867 $22.52 145
2024 Q2 20,105,197 $337,347,876 -$3,597,873 $16.77 138
2024 Q1 20,390,841 $263,815,399 +$3,583,180 $12.93 137
2023 Q4 47,930 $555,030 +$167,714 $11.58 2
2023 Q3 20,046,404 $256,933,558 +$494,723 $12.77 123
2023 Q2 19,964,604 $273,537,251 -$4,857,312 $13.70 126
2023 Q1 20,277,595 $310,648,368 +$5,584,904 $15.32 130
2022 Q4 19,601,051 $262,876,565 +$330,085 $13.41 126
2022 Q3 19,262,254 $256,038,464 -$10,530,671 $13.29 131
2022 Q2 20,349,533 $389,307,351 +$998,813 $19.13 133
2022 Q1 20,123,658 $400,685,521 +$4,201,111 $19.95 134
2021 Q4 19,887,882 $405,680,780 +$2,846,326 $20.42 129
2021 Q3 20,400,158 $439,452,951 -$19,141,749 $21.54 131
2021 Q2 21,196,096 $612,051,801 +$14,556,250 $28.88 140
2021 Q1 21,041,709 $513,496,005 +$22,209,393 $24.40 138
2020 Q4 20,317,802 $394,391,182 -$4,702,104 $19.42 130
2020 Q3 20,640,398 $359,154,334 -$519,334 $17.40 129
2020 Q2 44,667,289 $1,140,259,090 +$4,917,787 $26.27 148
2020 Q1 20,166,308 $487,360,691 +$96,523 $24.17 143
2019 Q4 20,551,201 $510,161,578 +$14,111,873 $24.83 146
2019 Q3 20,568,949 $438,977,105 -$15,639,057 $21.33 143
2019 Q2 21,020,238 $667,682,686 +$41,870,070 $31.77 160
2019 Q1 20,208,547 $666,888,078 +$7,329,731 $33.00 166
2018 Q4 20,247,442 $651,076,628 +$2,143,307 $32.16 186
2018 Q3 20,075,042 $861,269,342 +$18,999,405 $42.90 185
2018 Q2 19,595,638 $901,930,512 +$28,073,235 $46.05 168
2018 Q1 19,555,094 $776,412,353 +$30,692,314 $39.70 166
2017 Q4 19,188,985 $643,062,747 -$7,277,666 $33.50 161
2017 Q3 19,412,020 $719,055,576 +$13,099,880 $37.05 159
2017 Q2 19,090,056 $706,085,625 +$30,743,893 $37.05 163
2017 Q1 18,612,436 $523,049,692 +$93,603,662 $28.10 150
2016 Q4 18,453,294 $541,262,006 -$4,731,362 $29.30 138
2016 Q3 18,623,231 $506,139,803 +$7,596,905 $27.18 119
2016 Q2 18,724,682 $350,095,535 -$17,606,003 $18.66 119
2016 Q1 19,119,288 $517,236,100 -$23,011,451 $27.04 119
2015 Q4 19,884,510 $599,119,758 +$44,285,581 $30.13 118
2015 Q3 18,445,401 $583,464,237 +$40,069,227 $31.63 119
2015 Q2 16,841,942 $655,761,762 -$2,981,110 $38.94 116
2015 Q1 17,278,416 $611,524,303 -$1,057,791 $35.41 105
2014 Q4 17,571,677 $554,162,626 +$3,184,291 $31.55 88
2014 Q3 17,459,457 $391,263,678 +$65,699,500 $22.41 67
2014 Q2 14,541,585 $319,185,457 +$319,158,341 $21.95 63